Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of ...

The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...

In a pioneering move to transform citizen-centric policing, Punjab has become the first state in India to launch an Internal Police Reforms Project. The initiative, conceptualized by the Indian Police ...

Boehringer Ingelheim announced today that the FIBRONEERTM-IPF trial met its primary endpoint, which was the absolute change ...

Brittany Schlater dominated the 2024 CPU Canadian National Championships and unofficially broke the Raw Deadlift IPF World ...

A University of Colorado professor won the 2024 Alton Ochsner Award for his work on disease risk factors for idiopathic ...

Fintel reports that on September 23, 2024, EF Hutton initiated coverage of Reviva Pharmaceuticals Holdings (NasdaqCM:RVPH) ...

Insilico Medicine has announced positive preliminary results from its Phase IIa clinical trial of ISM001-055, a small ...

Ioannis Sapountzis, head of global therapeutic areas at Boehringer, said that FIBRONEER-IPF is the largest trial in IPF ...

Boehringer Ingelheim said that it will submit a new drug application for nerandomilast based on the positive results.

As relatively small open economies, South-East Asian emerging markets (Indonesia, Malaysia, Philippines and Thailand or ASEAN-4) are highly susceptible to external shocks—both financial and real—that ...

Ade Omisakin has managed to demolish the U83KG IPF Raw Total World Record at the 2024 IPF Western European Powerlifting ...